PIK3CA and head and neck squamous cell carcinoma: Furthermore, we found that HNSCC cells harboring PIK3CA mutations are particularly susceptible to undergo apoptosis upon mTOR and ERK inhibition, thus providing a new therapeutic option for PIK3CA+ HNSCC patients.